Adtran
ADTN
155 hedge funds and large institutions have $905M invested in Adtran in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 62 increasing their positions, 45 reducing their positions, and 25 closing their positions.
289% more call options, than puts
Call options by funds: $2.41M | Put options by funds: $619K
38% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 45
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $937M → $905M (-$31.3M)
2.35% less ownership
Funds ownership: 93.06% → 90.71% (-2.4%)
5% less funds holding
Funds holding: 163 → 155 (-8)
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$6.58M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$5.59M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$4.95M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.9M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
+$3.81M |
Top Sellers
ADTN Hedge Fund Activity: Q2 2017 in Review
155 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Adtran (ADTN) for Q2 2017, worth a combined $905M — down 3.3% from $937M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ADTN and 17 opened new positions — a net loss of 8 holders — while 45 trimmed existing stakes and 62 added.
The largest buyer was Renaissance Technologies, adding an estimated $6.58M. The largest seller was T. Rowe Price Associates, cutting an estimated $26.6M.
- 155 institutional investors held Adtran (ADTN) as of Q2 2017, down from 163 in Q1 2017.
- Funds reported $905M of Adtran stock for Q2 2017, down 3.3% quarter-over-quarter.
- 17 funds opened new Adtran positions in Q2 2017 and 25 closed out, a net change of -8 holders.
- The largest Adtran buyer in Q2 2017 was Renaissance Technologies, an estimated $6.58M added.
- The largest Adtran seller in Q2 2017 was T. Rowe Price Associates, an estimated $26.6M sold.
Based on aggregated 13F filings for Q2 2017.